An Open-label, Clinical Observation Extension Study to Assess Continuing Safety and Adherence in Patients With Postmenopausal Osteoporosis Receiving Monthly Oral Bonviva
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Acronyms ExBonAdAsia
- Sponsors Roche
- 18 Jun 2008 Status changed from in progress to completed according to Roche Site.
- 23 Apr 2007 New trial record.